Exenatide Twice Daily Versus Insulin Glargine for the Treatment of Type 2 Diabetes in Poland — Subgroup Data From a Randomised Multinational Trial GWAA
Endokrynologia Polska - Poland
doi 10.5603/ep.2013.0021
Full Text
Open PDFAbstract
Available in full text
Date
November 4, 2013
Authors
Publisher
VM Media SP. zo.o VM Group SK